Submit Deal

Submit Deal

Cover Image HEPAREGENIX

HEPAREGENIX

HEPAREGENIX

HQ - Tübingen

Summary

HepaRegeniX is a clinical stage company developing a novel regenerative therapy for the treatment of acute and chronic liver diseases

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 13 M

Avg. Deal Size£ 13 M

Market Context

Senior Management

Linda Greenbaum
Chief Medical Officer
Elias Papatheodorou
Chairperson

Sort

lg

linda greenbaum

Chief Medical Officer at HEPAREGENIX

Manager

1

Deal

£ 13 M

Total Value

ep

elias papatheodorou

Chairperson at HEPAREGENIX

Manager

1

Deal

£ 13 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite